PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,319,977
|
bronchial arteri embol manag frequent hemoptysi caus bronchiectasi retrospect evalu effect bronchial arteri embol bae compar conserv therapi treatment frequent hemoptysi caus bronchiectasi
|
D004621;D001987
|
T061;T047
|
36,319,976
|
identif valid novel signatur diagnost prognost biomark colorect cancer colorect cancer crc one common malign neoplasm worldwid although marker gene associ crc identifi previous fulfil therapeut demand therefor base differenti express gene deg studi aim establish promis valuabl signatur model diagnos crc predict patient prognosi
|
D015972;D015179
|
T045;T191
|
36,319,975
|
region left atrial conduct veloc anterior wall associ clinic recurr atrial fibril cathet ablat efficaci combin ipsilater low voltag area left atrial la conduct veloc cv electr remodel paramet atrial fibril af substrat howev pathophysiolog substrat la cv impact outcom cathet ablat af well evalu
|
D001281;D017115
|
T061;T047;T046
|
36,319,974
|
ad flavor potenti contributor bodi weight gain obes ad flavor marker ultra process food strong link exist intak ultra process food develop obes object present articl assess anim human data elucid impact ad flavor regul food intak bodi weight gain well defin area futur research
|
D015430;D009765
|
T033;T047
|
36,319,973
|
influenc adjuv chemotherapi dose intens overal surviv resect colon cancer multicent retrospect analysi colorect cancer remain second lead caus cancer death north america fluorouracil oxaliplatin base adjuv chemotherapi resect colon cancer cc reduc cancer recurr also caus signific toxic requir dose reduct effect dose intens surviv outcom fulli understood strengthen evid support inform decis make patient oncologist
|
D003110;D013736
|
T191
|
36,319,972
|
gender specif relationship frequenc food away home serum lipid level dyslipidemia chines rural adult food away home fafh one lead dietari pattern chines famili howev relationship fafh dyslipidemia remain unclear especi rural adult popul studi explor relationship fafh frequenc serum lipid level dyslipidemia rural chines adult
|
D050171
|
T047;T046
|
36,319,971
|
compar transcriptom analysi resist suscept kentucki bluegrass varieti respons powderi mildew infect poa pratensi one common cold season turfgrass use urban turf build also wide use ecolog environ manag worldwid powderi mildew common diseas p pratensi scientif ecolog control lawn powderi mildew molecular mechan under respons p pratensi powderi mildew infect must better understood
|
D031785;D001203
|
T004;T002
|
36,319,969
|
decomposit cast differenti life satisfact among older adult india multi cultur countri india vari social group larg shape live individu literatur shown life satisfact high associ social status individu howev chang age dynam grow older definit life among peopl press need understand whether addit year life older adult manifest dispar life satisfact among schedul cast sc schedul tribe st non scst social group recent year present studi explor factor contribut differ life satisfact across social group
|
D010549;D012923
|
T033;T098;T041;T080
|
36,319,968
|
diagnost prognost valu radiom deep learn technolog patient solid pulmonari nodul chest ct imag solid pulmonari nodul differ subsolid nodul diagnosi much challeng intend evalu diagnost prognost valu radiom deep learn technolog solid pulmonari nodul
|
D000077192;D008175;D000077321;D000230
|
T191;T066
|
36,319,967
|
nomogram predict hyperkalemia patient hemodialysi retrospect cohort studi hyperkalemia increas risk mortal cardiovascular relat hospit patient hemodialysi predictor hyperkalemia yet identifi aim develop nomogram abl predict hyperkalemia patient hemodialysi
|
D049451;D006947
|
T081;T033;T170
|
36,319,965
|
epidemiolog carbapenem resist klebsiella pneumonia st produc kpc shv ctx anhui china well known carbapenem resist klebsiella pneumonia crkp becom problemat public health issu due widespread spread worldwid china st type crkp preval crkp st type crkp recent preval high risk clone emerg wide throughout china pose serious public health risk therefor conduct epidemiolog outbreak st crkp produc ctx kpc shv tertiari hospit anhui china understand potenti risk current stt crkp outbreak
|
D007710;D000073182
|
T047;T007
|
36,319,964
|
plastom phylogenom analysi reveal evolutionari diverg polypodial subord dennstaedtiinea polypodial subord dennstaedtiinea contain singl famili dennstaedtiacea eleven genera speci includ group previous place dennstaedtiacea hypolepidacea monachosoracea pteridacea classif phylogenet relationship among eleven genera poor understood explor deep relationship within subord dennstaedtiinea estim earli diversif morpholog heterogen group analyz complet plastom sampl repres eleven genera subord dennstaedtiinea use maximum likelihood bayesian infer
|
D010802
|
T062;T078
|
36,319,963
|
waist hip ratio measur bioelectr imped analysi valuabl predictor chronic kidney diseas develop obes major health problem worldwid associ chronic kidney diseas ckd bodi mass index bmi common method diagnos obes concern accuraci abil measur bodi composit studi evalu risk ckd develop middl age popul associ various bodi composit metric prospect cohort middl age adult enrol baselin follow data avail collect data pertain particip bmi manual measur waist hip ratio whr various measur bioelectr imped analysi bia includ total bodi fat content muscl content calcul whr classifi particip quintil accord ckd defin estim glomerular filtrat rate egfr mlmin follow laboratori test increas bmi whr total bodi fat associ elev risk ckd increas total bodi muscl decreas risk among bodi composit metric whr measur bia highest predict valu ckd c statist addit particip healthi overweight defin low whr high bmi exhibit lower risk develop ckd compar normal weight obes defin high whr despit normal bmi conclus suggest central obes measur bia accur indic bmi predict develop ckd
|
D051436
|
T047
|
36,319,962
|
motor spare peripatellar plexus block provid noninferior block durat complet block area peripatellar region compar femor nerv block random control noninferior studi develop adequ region anaesthesia knee surgeri without affect lower limb mobil crucial periop analgesia howev report regard limit propos techniqu ultrasound guid peripatellar plexus pp block compar femor nerv fn block hypothes techniqu would provid noninferior block durat complet cutan sensori block peripatellar region without affect lower limb mobil investig conduct verifi hypothesi cadav volunt
|
D009407;D000765
|
T061
|
36,319,961
|
clinic profil comorbid treatment outcom stroke medic ward dessi comprehens special hospit northeast ethiopia retrospect studi undoubt stroke expand global public health issu stroke relat death attribut modifi risk factor demograph shift ethiopia increas preval stroke risk factor furthermor limit relev inform avail stroke therefor current studi sought evalu clinic profil comorbid treatment outcom stroke medic ward dessi comprehens special hospit
|
D001281;D020521;D006973
|
T047;T046
|
36,319,960
|
contribut earli life cognit reserv late life leisur activ success patholog cognit age identif factor specif influenc patholog success cognit age prerequisit implement diseas prevent promot success age howev multi domain behavior factor character differ success patholog cognit age clear yet
|
D058245;D000066492;D060825
|
T041;T048
|
36,319,959
|
associ violenc depress pregnanc perinat outcom moder mediat analysi assess direct indirect total effect violenc pregnanc perinat outcom evalu effect violenc moder mediat relationship depress perinat outcom
|
D000081983;D003863
|
T062;T184;T169;T048
|
36,319,958
|
clinic myopatholog molecular characterist chines patient dysferlinopathi high proport misdiagnosi novel variant dysferlinopathi autosom recess muscular dystrophi caus pathogen variant dysferlin dysf gene diseas show heterogen clinic phenotyp genet characterist
|
D049310;D049288
|
T047
|
36,319,957
|
genom wide character express analysi growth regul factor famili saccharum growth regul factor grfs transcript factor regul divers biolog physiolog process plant includ growth develop abiot stress although grf famili gene studi varieti plant speci knowledg identif express pattern grfs sugarcan saccharum spp still lack
|
D031786
|
T002
|
36,319,956
|
machin learn medicin practic introduct techniqu data pre process hyperparamet tune model comparison grow enthusiasm applic machin learn ml artifici intellig ai techniqu clinic research practic howev instruct develop robust high qualiti ml ai medicin scarc paper provid practic exampl techniqu facilit develop high qualiti ml system includ data pre process hyperparamet tune model comparison use open sourc softwar data
|
D001185;D000069550
|
T090;T073;T066
|
36,319,955
|
effect low dose aspirin applic pregnanc fetal congenit anomali extens use aspirin obstetr reproduct medicin concern potenti relat congenit anomali rais previous studi howev lack evid concern safeti applic aspirin pregnanc chines popul especi first trimest
|
D001241;D011295
|
T121;T058;T109
|
36,319,954
|
identif quantit trait loci relat trait stalk lodg resist use genom wide associ studi maiz zea may l stalk lodg one main factor affect maiz zea may l yield limit mechan harvest develop maiz varieti high stalk lodg resist requir explor genet basi lodg resist associ agronom trait stalk strength import indic evalu maiz lodg evalu measur stalk rind penetromet resist rpr stalk buckl strength sbs along morpholog trait stalk third internod length til fourth internod length fil third internod diamet tid fourth internod diamet fid trait associ stalk lodg resist
|
D040641;D003313
|
T168;T002;T028
|
36,319,953
|
nasopharyng aspir children sever communiti acquir pneumonia collect within day bronchoscopi partial reflect pathogen bronchoalveolar lavag fluid littl evid consist nasopharyng pulmonari pathogen children sever pneumonia studi aim compar differ pathogen nasopharyng aspir npas collect bronchoscopi bronchoalveolar lavag fluid balf children sever communiti acquir pneumonia scap
|
D011014;D014780;D018113;D017714;D012141
|
T047;T050;T005
|
36,319,952
|
mlago machin learn aid global optim micha constant estim kinet model kinet model power tool understand dynam behavior biochem system kinet model determin number kinet paramet micha constant k necessari global optim algorithm long use paramet estim howev convent global optim approach three problem comput demand ii often yield unrealist paramet valu simpli seek better model fit experiment observ behavior iii difficulti identifi uniqu solut multipl paramet set allow kinet model fit experiment data equal well non identifi problem
|
D008954;D000465
|
T170;T075
|
36,319,951
|
associ serum hydroxi vitamin gait speed handgrip strength patient hemodialysi muscl dysfunct preval dialysi patient gait speed handgrip strength simpl reliabl method assess muscl function numer observ studi link hydroxi vitamin oh status gait speed handgrip strength popul without kidney diseas studi aim evalu potenti associ oh status gait speed handgrip strength patient hemodialysi
|
D018737;D000072797
|
T081;T032;T040
|
36,319,950
|
util labor pain manag method associ factor among obstetr care giver public health institut east gojjam zone amhara region ethiopia facil base cross section studi labor pain unpleas sensori emot experi associ actual potenti tissu damag affect parturi fetus develop countri regular use obstetr analgesia develop countri includ ethiopia pain neglect women go pain labor studi conduct public health institut east gojjam zone amhara region ethiopia aim studi assess util labor pain manag method associ factor among obstetr care giver studi set
|
D017028;D048949
|
T184;T099;T098;T097
|
36,319,948
|
fals discoveri rate estim use candid peptid spectrum fals discoveri rate fdr estim import proteom target decoy strategi tds often use fdr estim estim fdr assumpt spectra identifi incorrect probabl spectra match target decoy peptid ident howev spectra match target decoy peptid probabl ident propos ctds target decoy strategi candid peptid accur estim fdr use probabl spectrum identifi incorrect target decoy peptid
|
D053719;D000465
|
T063;T170
|
36,319,947
|
non adher antihypertens medic lebanes adult hospit hypertens urgenc cost drug non adher assum play import role develop hypertens urgenc common health problem result frequent emerg depart admiss thus increas healthcar spend wastag object studi assess rate non adher antihypertens evalu influenc factor predict behavior lebanes hypertens adult addit studi aim estim cost hospit hypertens urgenc cover ministri public health patient non adher antihypertens
|
D000959;D006973
|
T121;T047
|
36,319,916
|
sulforaphan prevent revers allerg airway diseas mice via anti inflammatori antioxid epigenet mechan sulforaphan investig human patholog preclin model airway diseas provid mechanist insight explor l sulforaphan lsf ovalbumin ova induc chronic allerg airway murin model key hallmark asthma histolog analysi indic lsf prevent revers ova induc epitheli thicken collagen deposit goblet cell metaplasia inflamm well known antioxid anti inflammatori mechan contribut benefici effect lsf fourier transform infrar microspectroscopi reveal alter composit macromolecul follow ova sensit restor lsf rna sequenc human peripher blood mononuclear cell highlight anti inflammatori signatur lsf find indic lsf may alter gene express via epigenet mechan involv regul protein acetyl status lsf result histon tubulin hyperacetyl vivo cellular enzymat assay indic decreas express modest histon deacetylas hdac inhibit activ comparison well known pan hdac inhibitor suberoylanilid hydroxam acid saha molecular model confirm interact lsf lsf metabolit catalyt domain metal depend hdac enzym general studi confirm known mechan identifi potenti epigenet pathway account protect effect provid support potenti clinic util lsf allerg airway diseas
|
D000975;D006967
|
T123;T121;T039;T046;T044
|
36,319,913
|
impact phenotyp heterogen chemotact self organis capac aggreg chemosensit movement form paradigm self organis exampl span cellular anim system basic mechan assum phenotyp homogen popul secret attract well known system introduc five decad ago keller segel prove resolut popular model studi typic assumpt popul phenotyp homogen howev often lie odd heterogen natur system popul may compris distinct phenotyp vari accord chemotact abil attract secret etc initi understand divers impact autoaggreg propos simpl extens classic keller segel model popul divid two distinct phenotyp perform chemotaxi produc attract use combin linear stabil analysi numer simul demonstr switch phenotyp state alter capac popul self aggreg show switch base local environ popul densiti chemoattract level lead divers pattern provid rout popul effect curb size densiti aggreg discuss result context real world exampl chemotact aggreg well theoret aspect model global exist blow solut
|
D008954;D055641
|
T081;T075
|
36,319,901
|
vacuum foam dri method improv thermal stabil long term shelf life live attenu newcastl diseas virus vaccin vaccin use manag newcastl diseas virus ndv reli heavili cold chain result major constraint success applic ship storag studi undertaken improv thermotoler properti live attenu ndv vaccin use vacuum foam dri vfd technolog live attenu ndv vaccin formul trehalos gelatin pluron mmoll potassium phosphat buffer dri use vfd show improv heat toler comparison vaccin formul well dri use freez dri fd method formul vfd vaccin store c day c day c day virus titer loss decreas log contrast fd vaccin prepar could store c day furthermor formul ndv vfd vaccin remain infecti heat c min shelf life studi confirm improv thermal toler formul ndv vfd vaccin sinc could stabli store c month c month moreov immun month old specif pathogen free spf chicken formul ndv vfd vaccin store c could produc hemagglutin inhibit hi antibodi level compar commerci ndv fd vaccin requir strict adher cold chain conclus vfd technolog improv thermost long term shelf life vaccin also maintain immunogen
|
D009522;D002645
|
T005;T012
|
36,319,898
|
fluorometr assay base situ format silicon nanoparticl determin glucuronidas prodrug convert enzym glucuronidas gcase lysosom enzym particip releas glucos glucopyranosyl glycosid work first time develop analyt method exhibit fluorometr signal straightforward determin gcase use silicon nanoparticl si nps via hydrotherm treatment water bath c min dopamin da react aminoethylamino ethylamino propyltrimethoxysilan aeea produc green fluoresc si nps enlighten easi reaction gcase trigger specif hydrolysi dopamin glucuronid da gcu da design analyt method gcase sens product si nps therefor design sens platform gcase activ monitor limit detect lod studi ul furthermor feasibl method assess measur gcase activ human serum recoveri rsd rang respect
|
D012825;D053758
|
T196;T073
|
36,319,894
|
phototherm biosensor hpv base strand displac amplif gold nanoparticl use thermomet readout gold nanoparticl aunp aggreg state strong near infrar region nir absorpt caus much stronger phototherm effect dispers aunp strand displac amplif sda produc larg amount singl strand dna ssdna turn effect prevent aunp aggreg studi characterist appli design phototherm biosensor human papilloma virus hpv hpv chosen model target detect absenc hpv aunp aggreg state larg temperatur rise detect irradi nm laser presenc hpv trigger sda reaction help bst dna polymeras ntbstnbi nick endonucleas result product larg amount ssdna protect unmodifi aunp salt induc aggreg therefor aunp dispers state temperatur chang signific irradi nm laser differ temperatur chang appli quantit detect hpv use thermomet readout linear respons rang fm pm detect limit fm propos method appli detect hpv clinic cervic sampl compet clinic analysi
|
D053768;D015374
|
T059;T073;T075
|
36,319,878
|
exploit recent trend treatment androgen alopecia topic nanocarri minoxidil androgen alopecia polygenet disord character well defin hair loss progress gradual diseas affect male femal exert drastic impact person psycholog well minoxidil min common prescrib fda approv agent treatment diseas convent administ topic solut alli sever advers reaction erythema dermat result decreas patient complianc overcom side effect research develop various nanocarri min encapsul min various nanocarri enhanc entri drug hair follicl result format reservoir control deliveri drug also increas therapeut outcom comparison convent formul present review discuss composit physicochem properti differ nanocarri system min although success encapsul min observ nanocarri still scarc data regard load final dosag form allow research conduct vivo studi focus clinic applic highlight androgen alopecia polygenet disord gradual loss hair progress age minoxidil fda approv drug treatment androgen alopecia alli sever advers reaction decreas therapeut efficaci sever nanocarri includ polymer lipid base inorgan nanoparticl develop improv therapeut efficaci util nanocarri result increas retent min within hair follicl util low concentr solvent modif differ physicochem properti carrier ie particl size zeta potenti entrap effici import attain object
|
D008914;D053758
|
T121;T073;T109
|
36,319,877
|
infrar thermographi toolbox open access semi autom segment tool extract skin temperatur thorac region includ supraclavicular brown adipos tissu infrar thermographi irt wide use assess skin temperatur respons physiolog chang yet remain challeng standard skin temperatur measur repeat dataset develop open access semi autom segment tool irt toolbox measur skin temperatur thorac area estim supraclavicular brown adipos tissu scbat activ compar manual segment irt toolbox design python consist imag pre align non rigid imag registr toolbox test use dataset individu bmi kgm age year underw two cool procedur yield four imag per individu region interest roi delin two rater scbat deltoid area baselin imag toolbox enabl direct transfer baselin roi regist follow imag comparison rater also manual drew roi follow imag spatial roi overlap method rater determin use dice coeffici mean bias limit agreement mean skin temperatur method rater assess use bland altman analys roi delin time four time faster irt toolbox min manual delin min anatom area larg variabl roi placement method yet relat small skin temperatur differ found method scbat c loa c deltoid c loa c variabl skin temperatur rater compar method irt toolbox enabl faster roi delin maintain inter user reliabl compar manual delin trial registr number clinicaltrialsgov nct may
|
D002001;D012881
|
T032;T024
|
36,319,876
|
reliabl gas phase tautom equilibria drug like molecul scaffold issu continuum solvat accur calcul relat tautom energi differ environ prerequisit mani paramet relev drug discoveri work provid thorough benchmark semiempir method pm gfn xtb forc field opl hartre fock hf c densiti function pbeh c b c rscan c pbe pbe tpss rscan bx v x blyp bplyp second order perturb theori mp versus gold standard coupl cluster dlpno ccsd use def qzvpp basi set outperform method identifi x wherea rscan c best perfom one set cost optim method applic two method challeng subset sampl challeng provid evid deviat experi caus defici current continuum solvat method
|
D055808
|
T062
|
36,319,873
|
infect decapod iridesc virus emerg diseas shrimp cultur last decad shrimp industri plagu mani destruct diseas result sever product econom loss mani aquacultur countri includ viral bacteri parasit diseas recent anoth emerg viral diseas threaten shrimp cultur industri asia virus origin call cherax quadricarinatus iridovirus cqiv shrimp hemocyt iridesc virus shiv classifi within propos genus decapodiridovirus formal name decapod iridesc virus div intern committe taxonomi virus ictv virus first detect earli cherax quadricarinatus sampl fujian provinc farm white leg shrimp penaeus vannamei sampl zhejiang provinc review articl encompass signific div implic futur global aquacultur
|
D007497;D033561;D014777
|
T005;T204;T047
|
36,319,866
|
hand assist versus straight laparoscopi colorect surgeri systemat review meta analysi hand assist laparoscop surgeri hal altern straight laparoscopi lap colorect surgeri mani studi compar two term efficaci complic outcom meta analysi aim uncov signific differ convers rate oper time bodi mass index bmi incis length intraop postop complic length stay
|
D003107;D010535
|
T060;T091;T061
|
36,319,854
|
ionic silver coat prevent implant associ infect anaerob bacteria vitro vivo mice current implant util clinic bone transplant procedur howev infecti osteomyel occur implant site remov bacteria challeng moreov alter blood flow peri implant infecti site creat anaerob environ make difficult treat infect antibiot thus would benefici implant could modifi exhibit antibacteri activ even anaerob condit show antibacteri activ silver ion coat titanium rod even anaerob bacteria porphyromona gingivali p gingivali vitro vivo specif implant silver coat control uncoat titanium rod along p gingivali mous femor bone bm caviti observ signific inhibit p gingivali infect silver coat compar non coat rod base vivo bio imag osteonecrosi infecti osteomyel elev inflammatori factor c reactiv protein il promot p gingivali also signific reduc presenc silver coat rod overal studi indic silver ion coat implant repres therapeut option prevent associ infect even anaerob condit anaerob bacteria
|
D012834;D010019
|
T196;T047
|
36,319,844
|
discoveri four plasmat biomark potenti predict cardiovascular outcom peripher arteri diseas peripher arteri diseas pad patient increas cardiovascular risk despit pharmacolog treatment strategi biomark research improv risk stratif focus known atherothrombot pathway unexplor pathway might play import role explor associ broad cardiovascular biomark set cardiovascular risk pad pad outpati enrol observ cohort studi patient follow one year composit endpoint myocardi infarct coronari revascular stroke acut limb ischemia mortal assess patient data blood sampl collect upon inclus citrat platelet poor plasma use analyz biomark olink cardiovascular panel ii iii use proxim extens assay fifteen patient reach composit endpoint patient prior stroke higher serum creatinin level multivari analysi reveal increas plasma level proteas activ receptor par galectin gal tumor necrosi factor receptor superfamili member tnfrsfa interleukin il predict cardiovascular event mortal posit regul acut inflammatori respons leukocyt chemotaxi identifi involv biolog process studi identifi il par gal tnfrsfa potent predictor cardiovascular event mortal pad potenti drug develop target
|
D058729;D020521
|
T047
|
36,319,843
|
serum extracellular trap associ activ myeloid cell sle patient low level anti dna antibodi neutrophil extracellular trap net involv system lupus erythematosus sle sought cluster sle patient base serum net level serum net level higher sle patient healthi control frequenc pleuriti myositi increas patient high serum net level serum net level negat correl anti doubl strand dna anti dsdna antibodi titer cq bind immun complex posit correl c reactiv protein crp monocyt count neutrophil transcriptom analysi demonstr differ net associ signatur irrespect serum net level suggest anti dsdna antibodi mediat clearanc net serum net level signific correl myeloid cell deriv inflammatori molecul serum net base cluster analysi reveal group patient base serum net crp level anti dsdna antibodi titer monocyt count monocyt consist activ follow net contain immun complex net ic stimul conclus sle patient high serum net level lower anti dsdna antibodi titer higher inflammatori respons net ic stimul monocyt might associ inflammatori respons character elev crp level find appli precis medicin inflammatori process rather antibodi depend process target specif subpopul sle patient
|
D065206;D008180
|
T026;T047
|
36,319,840
|
extend coagul profil children long covid prospect studi emerg data suggest endotheliopathi chang associ post covid condit pcc adult research matter children lack analyz extend coagul profil includ biomark endotheli damag children pcc compar control group children fulli recov post sar cov infect case control studi enrol children year age previous microbiolog confirm sar cov infect pediatr post covid unit itali week initi infect sampl taken week sar cov diagnosi analyz coagul profil fibrinogen prothrombin time intern normal ratio activ partial thromboplastin time dimer factor viii coagul activ plasma von willebrand factor vwf antigen vwf ristocetin cofactor rc compar coagul profil sampl children identifi pcc least one three symptom could explain altern diagnosi week follow assess use pediatr long covid intern sever acut respiratori emerg infect consortium isar survey seventi five children enrol femal median age iqr year forti six children least one persist symptom eight week post onset pcc persist symptom week pcc least three persist symptom pcc week children pcc present frequent abnorm dimer level refer rang compar children fulli recov week vs p week follow vs p children three symptom week follow compar recov vs p coagul profil abnorm valu detect vwf fviii rc fibrinogen signific differ children pcc compar control although major children cohort show coagul profil within close normal rang found higher proport children pcc specif sever spectrum character three persist symptom abnorm dimer level compar children fulli recov acut sar cov infect
|
D000086382
|
T047;T067
|
36,319,838
|
task demand load carriag experi affect gait variabl among militari cadet load carriag inevit daili task soldier purpos studi explor extent gait variabl gv affect load carriag experi among militari cadet whether experi relat differ gv depend task demand two group cadet experienc less experienc complet load carriag task three load condit load kg kg three categori gv measur obtain spatiotempor variabl joint kinemat variabl lyapunov expon compar tradit mean gait measur gv measur discrimin experi although group show similar mean gait measur experienc particip reduc variabl spatiotempor measur p joint kinemat p well lower level long term local dynam stabil ankl p group heavier load also caus increas gv p enhanc short term local dynam stabil knee p result emphas import gv measur may provid complet descript adapt stabil control highlight altern movement strategi difficult load carriag captur experi relat differ load carriag strategi
|
D008889
|
T097
|
36,319,836
|
immun mobilis cell receptor redirect polyclon cd cell chronic hiv infect form immunolog synaps cell exhaust develop human immunodefici virus hiv infect due chronic viral antigen stimul adapt respons primarili affect virus specif cd cell may remain dysfunct despit viral load reduc antiretrovir therapi howev abnorm may also evid non hiv specif popul could limit efficaci cell therapi viral reservoir show bulk polyclon cd cell peopl live hiv plwh express propos marker dysfunct hiv specif cell high level yet form lytic immunolog synaps elimin primari rest infect hiv gag lo cd cell redirect potent bispecif cell retarget molecul immun mobilis monoclon cell receptor tcr virus immtav plwh cd cell function impair compar cd cell hiv nave donor immtav redirect enabl elimin gag lo cd cell insensit autolog hiv specif cytolyt cell immtav molecul may therefor abl target hiv reservoir repres major barrier cure
|
D015658;D015497
|
T047;T005
|
36,319,835
|
symbiont genotyp influenc holobiont respons increas temperatur coral reef face warm ocean increas coral bleach whiten coral due loss microalg endosymbiont possibl evolutionari rescu offer hope reef persist tight link mutual evolutionari rescu may occur evolut host andor endosymbiont mani oblig mutual compos relat small fast grow symbiont greater potenti evolv ecolog relev time scale relat larg slower grow host numer jellyfish speci harbor close relat endosymbiont taxa cnidarian speci coral common use model system investig cnidarian mutual examin potenti adapt upsid jellyfish cassiopea xamachana increas temperatur via evolut microalg endosymbiont symbiodinium microadriaticum quantifi trait variat among five algal genotyp respons three temperatur c c c fit host infect genotyp genotyp show posit growth rate temperatur rate respir photosynthesi decreas increas temperatur respons vari among genotyp unrel genet similar effect temperatur asexu reproduct time develop host also depend genotyp symbiont natur select could favor differ algal genotyp differ temperatur affect host fit eco evolutionari interact may critic compon understand speci resili increas stress environ
|
D037421;D004141
|
T204
|
36,319,833
|
drosophila ppk encod proton gate mechanosensit ion channel drosophila larva nocicept mdiv sensori neuron detect divers noxious stimuli prompt nocicept roll respons intrigu neuron also regul stereotyp larval movement channel respons transduc stimuli electr signal yet fulli identifi undertook genet electrophysiolog analysi ppk member degenac famili cation channel ppk mutant exhibit impair nocicept roll respons upon mechan forc acid impair respons noxious temperatur gentl touch mutant also exhibit defect larval movement rnai ppk mdiv neuron likewis produc larva defect mechan acid nocicept larval movement impair detect heat gentl touch cultur cell transfect ppk produc current acid hypoton solut suggest ppk encod ion channel respond acid cell swell taken togeth find suggest ppk act mdiv neuron proton mechano gate ion channel mediat acid mechano respons nocicept larval movement
|
D004330;D004331
|
T204
|
36,319,832
|
novel refin pyroptosi inflammasom relat gene signatur predict prognosi immun microenviron pancreat ductal adenocarcinoma pyroptosi inflammatori form cell death play key role develop auto inflamm cancer studi aim construct pyroptosi inflammasom relat gene predict prognosi pancreat ductal adenocarcinoma pdac studi base primarili one way analysi varianc univari cox regress analysi least absolut shrinkag select oper lasso cox regress risk prognost signatur gene set variat analysi gsva immun microenviron analysi use pdac data cancer genom atlas intern cancer genom consortium databas analysi role pyroptosi inflammasom relat gene pdac retriev reactom genecard databas last collect six pair pdac match normal adjac tissu sampl verifi express signatur gene quantit real time pcr qrt pcr identifi candid pyroptosi inflammasom relat gene differ signific patholog grade stage pdac patient univari cox lasso analys point six gene best variabl construct prognost signatur includ acta cqtnf dnah gatm lbp ngf result risk prognost model indic auc year greater gsva reveal glycolysi p pathway kras signal inflammatori respons hallmark gene set associ risk score high risk group associ poor prognosi character lower infiltr cell involv anti tumor immun wherea low risk group higher cell nk cell macrophag show relat better surviv signific higher upregul cytolyt score inflamm score addit crucial pyroptosi inflammasom relat gene valid qrt pcr studi reveal prognost role pyroptosi inflammasom relat gene pdac first time simultan biolog prognost heterogen pdac demonstr deepen molecular understand tumor
|
D021441;D010190
|
T191
|
36,319,826
|
cytokin help suggest aplast anemia pulmonari bacteri co fungal infect although aplast anemia aa come categori blood malign diseas infect frequent occur bone marrow failur make wors pulmonari infect preval limit clinic diagnosi find biomark predict bacteri bacteri combin fungal infect lung review aa medic record includ without infect pure pulmonari bacteri infect bacteri fungal infect review substanti chang il f il ifn il il il level non infect lung bacteri infect group p signific variat il tnf il il il il il il il il p uninfect group pulmonari bacteri fungal infect group p observ result reveal signific differ tnf il p il il il pulmonari bacteri infect group fungal infect group p moreov calcul roc cut valu determin il auc cut pgml p signific advantag cytokin bodi temperatur auc p pct auc p crp auc p detect lung bacteri infect addit il auc cut pgml p il auc cut pgml p show stronger advantag cytokin bodi temperatur auc p pct auc cut ngml p crp auc cut mgl p distinguish bacteria fungi may suggest il may play role differenti co infect bacteria fungi advantag repeat sever aplast anemia saa sever aplast anemia vsaa conclus aberr il elev aa patient may predict likelihood bacteri lung infect concurr increas il il hand signal bacteri fungal infect patientsthes find may help suggest bacteri fungal co infect patient aa focus vsaa saa
|
D000741;D001424;D060085;D009181
|
T047
|
36,319,823
|
biolog activ antioxid potenti differ biosynthes nanoparticl moringa oleifera scienc nanotechnolog expand daili potenti benefit peopl moringa oleifera abund sourc phenol compound bioactiv substanc recognis necessari plant medicin potenti wide varieti health benefit aim current studi examin antioxid antibacteri cytotox effect five nanoparticl la cuo fe ag zno made use bioactiv chemic aqueous extract moringa oleifera leav four human cell line td hepg wi uv visibl spectroscopi analysi surfac plasmon peak nm rang valu zeta potenti various biosynthes nanoparticl rang mv indic repuls particl stabil formul nanoparticl confirm format nanoparticl addit dpph method use assess antioxid activ five distinct metal nanoparticl result show method work parallel depend concentr nps incub time anticanc effect synthes nanoparticl four differ cell line test cytotox assay show dose depend time depend effect nanoparticl obtain result conclud accept potenc td cell line ic rang gml gml respect howev hepg wi cell line show relat higher resist test nanoparticl compar doxorubicin moreov antibacteri result reveal silver nanoparticl exhibit highest antibacteri activ enterococcus faecali staphylococcus aureus nanoparticl high therapeut activ low concentr open new avenu develop novel therapeut approach human pathogen
|
D029588;D053768
|
T073;T002
|
36,319,821
|
valid day aliv hospit new patient center outcom quantifi life impact heart transplant number patient wait heart transplant htx increas thus identif outcom relev factor crucial studi aim identifi periop factor associ day aliv hospit daoh patient center outcom quantifi life impact htx retrospect cohort studi screen patient underw htx univers hospit duesseldorf germani septemb decemb primari endpoint daoh year risk factor mortal htx assess univari analysi variabl signific associ enter multivari quantil regress total patient includ analysi median daoh year day univari analysi follow variabl associ reduc daoh recipi donor diabet pre htx renal replac therapi rrt va ecmo therapi recipi bodi mass index recipi estim glomerular filtrat rate egfr postop durat mechan ventil adjust mechan ventil rrt egfr recipi diabet show signific independ associ daoh studi identifi risk factor associ reduc daoh year htx find might complement exist data outcom patient undergo htx
|
D006333;D016027
|
T061;T047;T046
|
36,319,819
|
vitro regener histolog characterist dioscorea nipponica makino dioscorea nipponica makino optim candid develop diosgenin industri north china due increas demand medicin industri urgent appli new biotechnolog tool foster breed desir trait enhanc secondari metabolit product product use metabolit vitro cultur rhizom explor success util various food drug industri studi report callus format plantlet regener medicin plant nipponica explant leav stem segment rhizom asept seedl cultur murashig skoog ms medium contain various combin auxin cytokinin find optim pgrs type explant callus induct shoot regener nipponica paraffin section techniqu also use observ morphogenesi callus adventiti bud explant seed rhizom form calli high frequenc line examin howev explant leav rare form callus three kind callus detect induct phase describ three type callus callus iii differ structur characterist greenish color nodul like protrus surfac callus type iii arrang close cell less interstiti substanc cell differenti abil stronger callus type optimum combin maximum shoot differenti frequenc callus deriv seed cultur ms medium mg l ba mg l naa shoot differenti frequenc rhizom induc callus obtain combin ms medium supplement mg l ba mg l naa ms medium plus mg l naa result higher root regener frequenc vitro propag plantlet healthi root domest transplant small plastic pot contain steril soil rite greenhous condit surviv bud differenti most exogen origin most occur near callus surfac therefor may surmis vitro morphogenesi nipponica main caus indirect organogenesi adventiti bud
|
D027742
|
T168;T002
|
36,319,817
|
meta analysi epigenom wide associ studi major depress disord epigenet mechan hypothes play role etiolog major depress disord mdd studi perform meta analysi two case control mdd cohort identifi differenti methyl posit dmps differenti methyl region dmrs mdd use sampl two cohort total mdd case control repeat sampl averag samplessubject perform ewa meta analysi multipl cytosin phosphat guanin site annot tnnt associ mdd reach studi wide signific includ cg p among dmps associ p valu less pathway reactom ras activ upon ca influx nmda receptor p p adjust long term potenti p p adjust enrich studi total dmrs sidak correct p valu identifi meta analysi includ dmrs annot tnnt chr probe sidak correct p valu sa chr probe sidak correct p valu nrxn chr probe sidak correct p valu ilra chr sidak correct p valu npffr chr sidak correct p valu use cohort depress case control sampl identifi dmps dmrs associ mdd molecular pathway implic data includ mechan involv neuron synapt plastic calcium signal inflamm consist report previous genet protein biomark studi indic mechan involv neurobiolog depress
|
D000081122;D003865
|
T028;T048
|
36,319,814
|
preval characterist dri eye diseas parkinson diseas systemat review meta analysi investig character preval dri eye diseas ded parkinson diseas pd pubm embas databas search relev studi januari march qualiti assess use joanna brigg institut critic apprais checklist studi specif estim combin use dersimonian laird random effect model preval subject ded symptom patient pd mean differ blink rate corneal thick tear film breakup time tear secret volum schirmer test compar control studi patient pd includ qualit quantit synthes respect meta analysi reveal preval subject ded symptom pd compar control patient pd signific lower blink rate thinner corneal thick shorter tear film breakup time lower tear secret volum schirmer test without anesthesia
|
D010300;D015352
|
T184;T047
|
36,319,811
|
bmi variabl incid diabet mellitus tehran lipid glucos studi tlgs previous epidemiolog studi debat associ bodi mass index bmi trend cardiovascular diseas mortal studi aim evalu associ bmi variabl slope incid type diabet mellitus tdm sex stratifi year follow popul base tehran lipid glucos studi tlgs individu age year subject includ follow year slope coeffici bmi linear regress model repres individu bmi trend incid dm root mean squar error rmse bmi linear trend select reflect bmi variabl six follow up cox proport hazard regress use investig associ baselin bmi bmi slope rmse incid tdm among men women multivari adjust hrs tdm sd increment bmi slope ci p normal weight men ci p overweight obes men howev women sd increment bmi slope increas risk tdm hr ci p normal weight ci p women bmi kgm men baselin bmi kgm bmi rmse associ decreas risk tdm hr ci p baselin bmi associ risk diabet men women posit bmi slope associ develop diabet sex associ bmi variabl incid tdm differ accord sex baselin bmi bmi variabl associ lower risk tdm overweight obes men bmi variabl women baselin bmi gender relat risk tdm
|
D050177;D003924
|
T033;T047
|
36,319,803
|
dairi intak relat metabol health status overweight obes adolesc lack evid associ dairi intak metabol health status overweightobes adolesc studi evalu associ dairi intak metabol health status overweightobes iranian adolesc overweightobes adolesc n boy girl select multistag cluster random sampl method particip cross section studi dietari intak assess use valid item food frequenc questionnair anthropometr indic blood pressur fast glucos insulin lipid profil measur particip categor metabol healthi obes mho metabol unhealthi obes muo accord intern diabet feder idf criteria combin idf homeostasi model assess insulin resist homa ir criteria frequenc muo base idf idfhoma ir definit respect fulli adjust model particip highest tertil dairi intak lower odd muo base idf criteria ci higher dairi intak associ non signific lower risk muo accord idfhoma ir definit maxim adjust model ci stratifi analysi sex bodi mass index reveal associ stronger girl overweight subject furthermor higher intak low fat dairi relat reduc likelihood muo higher intak high fat dairi relat increas odd muo communiti base cross section studi reveal higher intak dairi associ signific lower odd muo among iranian adolesc especi girl overweight subject
|
D063766;D007333;D024821
|
T033;T047;T046
|
36,319,798
|
explor mechan andrographolid treatment gastric cancer network pharmacolog molecular dock gastric cancer emerg key challeng oncolog research malign tumour advanc stage detect apart surgic manag pharmacotherapeut approach stomach cancer treatment appeal option consid andrographolid shown anticanc chemosensit properti varieti solid tumor includ stomach cancer exact molecular mechan skeptic studi identifi valid pharmacolog mechan involv treatment gc integr approach network pharmacolog molecular dock target andrographolid gc obtain databas intersect target andrographolid gc relat gene use construct protein protein interact ppi network furthermor mechan action target predict gene ontolog go kyoto encyclopedia gene genom kegg pathway enrich analys final result valid molecular dock experi mrna protein express level total target obtain andrographolid treat gc function enrich analysi reveal target gene exert promis therapeut effect gc hif pik akt signal pathway possibl mechan action inactiv hif signal pathway depend inhibit upstream pik akt pathway ppi network identifi src akt tp stat pikca mapk mapk vegfa jun hspaa potenti hub target addit result valid molecular dock experi surviv analysi indic express level hub gene signific associ clinic prognosi gc studi provid novel approach reveal therapeut mechan andrographolid gc make futur clinic applic andrographolid treatment gc
|
D013274;D004365
|
T121;T123;T191
|
36,319,793
|
fabric examin polyorganophosphazenepolycaprolacton base scaffold degrad vitro vivo behavior suitabl tissu engin applic present studi aim synthesi proper scaffold consist hydroxyl polyphosphazen polycaprolacton pcl focus potenti use tissu engin applic first graft pcl poli propylen glycol phosphazen ppgp perform via rop caprolacton wherea ppgp act multisit macroiniti prepar poli propylen glycol phosphazen graft polycaprolacton ppgp g pcl evalu essenti test includ nmr ftir fesem ed tga dsc contact angl measur quantum calcul perform investig molecular geometri energi homo lumo ppgp g pcl materi studio md simul appli describ interact polym phospholipid membran popcb materi studio cc l cell use probe cell surfac interact synthet polym surfac cell adhes prolifer onto scaffold evalu use fesem mtt assay vitro analysi indic enhanc cell adhes high prolifer rate excel viabil scaffold cell type polym test via intraperiton implant mice show evid advers inflamm necrosi site scaffold implant return osteogenesi new form bone vivo degrad scaffold observ herein vitro vivo assess confirm ppgp g pcl appropri scaffold tissu engin applic
|
D023822;D054457
|
T061;T122
|
36,319,771
|
analysi caudat nucleus transcriptom individu schizophrenia highlight effect antipsychot new risk gene studi gene express brain individu schizophrenia focus cortic region subcort nuclei striatum promin implic diseas current antipsychot drug target striatum dens dopaminerg innerv perform comprehens analysi genet transcript landscap schizophrenia postmortem caudat nucleus striatum individu neurotyp individu individu schizophrenia individu bipolar disord african european ancestri integr express quantit trait loci analysi mendelian random latest schizophrenia genom wide associ studi transcriptom wide associ studi differenti express analysi identifi mani gene associ schizophrenia risk includ potenti dopamin receptor short isoform found antipsychot medic extens influenc caudat gene express construct caudat nucleus gene express network highlight interact involv schizophrenia risk analys provid resourc studi schizophrenia insight risk mechan potenti therapeut target
|
D014150;D012559
|
T121;T039;T048
|
36,319,770
|
synapt prune glial synaps engulf upon motor learn synapt prune fundament process neuron circuit refin learn memori accumul evid suggest glia particip sculpt neuron circuit synaps engulf howev whether glial involv synapt prune role memori format remain elus use newli develop phagocytosi report mice three dimension ultrastructur character found synapt engulf cerebellar bergmann glia bg frequent occur upon cerebellum depend motor learn mice observ increas pre postsynapt nibbl bg along reduct spine volum learn pharmacolog blockad engulf annexin v inhibit spine volum reduct overnight improv motor adapt result indic bg contribut refin matur cerebellar cortic circuit synapt engulf motor learn
|
D009457;D013569
|
T025;T030
|
36,319,767
|
potenti synergist effect alhagi graecorum ethanol extract two convent food preserv foodborn pathogen present studi aim screen anti bacteri activ synergist interact graecorum boiss ethanol extract two food preserv five strain foodborn bacteria disk diffus minimum inhibitori concentr use anti bacteri assay checkerboard assay time kill curv use combin studi hplc analysi molecular dock studi perform corrobor vitro result ethanol extract show anti bacteri activ test bacteri strain inhibit zone mm mic valu rang mg ml combin ethanol extract na benzoat na propion result synergist addit interact test bacteria fraction inhibitori concentr index fici rang antagon shown time kill curv assay show synergist addit combin inhibitori effect test strain ethanol extract combin na benzoat na propion use develop new sourc food preserv test new differ natur plant extract food preserv help develop new anti bacteri agent
|
D005520;D007887
|
T120;T002
|
36,319,758
|
luminesc probe base terbium base metal organ framework organophosphorus pesticid detect terbium base metal organ framework tb mof prepar mild condit util construct fluoresc probe determin organophosphorus pesticid op coupl acetylcholinesteras ach acetylcholin chlorid ach cholin oxidas cho sinc op obvious inhibit activ ach tb mofachchoach system detect op accomplish restor fluoresc tb mof result reduc product h take chlorpyrifo cpf pesticid model method exhibit high sensit linear rang gl limit detect lod gl optimum condit ex nm em nm tb mofachchoach fluoresc system high select cpf method success appli detect cpf tap water strawberri sampl recoveri tap water strawberri free complic fabric oper tb mof base system rapid simpl stabl provid refer new way design op fluoresc probe futur
|
D010575;D000073396;D004390
|
T131;T109
|
36,319,750
|
anti liver fibrosi activ curcuminchitosan coat green silver nanoparticl liver fibrosi result hepat accumul extracellular matrix accompani failur mechan respons matrix dissolut pathogenesi liver fibrosi associ mani protein differ cell type present studi silico molecular dock analysi reveal curcumin may inhibit fibrosi mediat protein pdgf pdgfrb timp tlr direct bind nano formul overcom curcumin problem increas efficaci curcumin drug maxim solubl bioavail enhanc membran permeabl improv pharmacokinet pharmacodynam biodistribut therefor green silver nanoparticl agnp synthes presenc sunlight mean metabolit streptomyc malachiticus coat curcumin chitosan mixtur serv drug deliveri tool curcumin target ccl induc liver fibrosi mous model fibrosi induct signific increas hepat gene express cola sma pdgfrb timp elev hepat enzym increas histopatholog find increas collagen deposit determin mason trichrom stain treatment nake agnp tend increas inflammatori effect coat chitosan similar treatment curcumin prevent fibrogen effect ccl induct liver fibrosi revers concurr treatment curcuminchitosan coat agnp nano form curcumin found effici anti liver fibrosi drug maintain hepat architectur function fibrosi develop efficaci attribut inhibitori role direct bind fibrosi mediat protein pdgfrb timp tlr tgf
|
D003474;D048271;D053768;D053758
|
T121;T130;T073;T109
|
36,319,747
|
chang subcutan adipos tissu microrna express respons exercis train obes african women mechan underli exercis induc adapt adipos tissu elucid yet accumul studi suggest import role microrna mirna studi aim investig mirna express gluteal subcutan adipos tissu gsat respons week exercis intervent south african women obes assess depot specif differ mirna express gsat abdomin subcutan adipos tissu asat addit associ exercis induc chang mirna express metabol risk evalu women underw week supervis aerob resist train n maintain regular physic activ period n exercis induc mirna identifi gsat use illumina sequenc follow analysi differenti express mirna gsat asat use quantit real time pcr associ chang pre post exercis train mirna express metabol paramet evalu use spearman correl test exercis train signific increas express mir p fold p mir p fold p mir p fold p gsat asat addit novel mirna myn identifi gsat low express asat exercis induc differ mirna express correl associ chang high densiti lipoprotein concentr exercis train induc adipos depot specif mirna express within subcutan adipos tissu depot south african women obes signific associ exercis induc mirna metabol risk warrant investig
|
D050151;D035683
|
T123;T024;T114
|
36,319,744
|
refer gene express stabil avena sativa l compat incompat interact puccinia gramini reliabl qpcr experi requir select refer gene stabl level express given experiment system studi attempt determin refer gene rgs sativa p gramini experiment setup evalu nine candid refer gene sativa oat line pg cultivar kasztan compat incompat interact differ pathotyp puccinia gramini f sp avena six time point post inocul identif gene high express stabil perform four algorithm genorm normfind bestkeep ct method found appropri combin rgs rt qpcr data normal hnr heterogen nuclear ribonucleoprotein c efa elong factor alpha eifa eukaryot initi factor worst candid normal dataset cyp cyclophilin tua alpha tubulin identifi refer gene suitabl candid standard gene express studi sativa p gramini interact system potenti relat pathogen date first report rgs select pathosystem
|
D018554;D017343
|
T028;T002
|
36,319,742
|
overnight dynam scale free oscillatori spectral paramet nrem sleep eeg unfold overnight dynam human sleep featur play pivot role understand sleep regul studi reveal complex reorgan frequenc composit sleep electroencephalogram eeg cours sleep howev scale free oscillatori measur remain undistinguish improp character focus first four non rapid eye movement nrem period night sleep record healthi human subject year reveal flatten spectral slope decreas sever measur spectral intercept consecut sleep cycl slope intercept signific predictor slow wave activ swa gold standard measur sleep intens overnight increas spectral peak size amplitud relat scale free spectra broad sigma rang parallel u shape time cours peak frequenc frontopolar region although set spectral indic analyz herein reproduc known age sex effect interindividu variabl spectral slope steep lower compar variabl swa find indic distinct scale free oscillatori measur sleep eeg could provid composit measur sleep dynam low redund potenti afford new insight sleep regulatori process futur studi
|
D004569;D000077310
|
T060;T039;T034
|
36,319,741
|
geobiom perspect kidney stone recurr reactiv surfac area swl deriv particl shock wave lithotripsi swl effect common appli clinic treatment human kidney stone yet success swl counterbalanc risk retain fragment caus recurr stone format may requir retreat studi appli geobiom experiment analyt approach determin size frequenc distribut fractur pattern reactiv surfac area swl deriv particl within context origin crystal growth structur crystallin architectur reveal confoc autofluoresc caf super resolut autofluoresc sraf microscopi multipl calcium oxal caox stone remov mayo clinic patient use standard percutan nephrolithotomi pcnl shock puls lithotripsi spl produc approxim mm diamet pcnl deriv fragment experiment treat ex vivo swl form hundr smaller particl fractur propag crystallin architectur pcnl deriv fragment varieti geometr orient form rectangular point concentr spall irregular swl deriv particl size frequenc distribut rang fine silt fine pebbl mm accord wentworth grain size scale mean size fine sand import swl deriv particl smaller mm diamet detect limit clinic comput tomographi ct techniqu retain intern kidney membran surfac creat clinic undetect crystal seed point extrem high reactiv surfac area dramat enhanc multipl event crystal dissolut diagenet phase transit may lead high rate caox kidney stone recurr swl treatment
|
D008096;D007669;D000074642
|
T061;T047
|
36,319,740
|
microdamag analysi singl use flexibl ureteroscop immedi lithotripsi use prospect ex vivo studi investig microdamag singl use flexibl ureteroscop fur ureteroscopi endoscop combin intraren surgeri ecir perform wiscop devic otu medic san jose ca usa examin immedi use divid three equal group ureteroscopi ecir prone supin posit overal scope microdamag assess includ scope deflect bend radius resolut water flow rate addit analyz associ scope status surgic paramet deflect bend radius resolut remain similar threshold group howev water flow rate threshold seven scope ureteroscopi group none ecir group p univari multivari logist regress analys demonstr basket wire cathet use associ increas risk overal scope microdamag odd ratio p p respect stone size total laser energi surgic posit associ risk scope microdamag conclus ureteroscopi close associ scope damag ecir basket wire cathet use seem inflict damag fur
|
D008096;D007669
|
T061;T047
|
36,319,739
|
relationship nitrapyrin vari nitrogen applic rate nitrous oxid emiss nitrogen use effici maiz file reduc nitrogen loss accomplish mix fertil nitrif inhibitor ni agricultur system increas soil n suppli capac use ni could lead improv n use effici nue increas crop yield studi examin effect differ n rate ni maiz north iran maiz fertil urea three level kg nha alon nitrapyrin ni increas n applic rate result consider rise grow season n emiss nitrapyrin use n emiss dramat reduc ni treatment reduc n emiss growth season kg nha respect ni treatment reduc yield scale n emiss lowest quantiti yield scale n found n ni g n n kg n uptak addit grain yield increas appli ni n n n n n result show n ni n treatment show highest lowest nue respect final find show ni reduc n emiss increas nue yield applic method rate nitrapyrin applic need improv order maxim mitig potenti
|
D009609;D009584
|
T123;T197;T121;T196
|
36,319,734
|
surviv rate predictor mortal among tbhiv co infect adult patient retrospect cohort studi nowaday tuberculosi remain major caus hiv associ mortal account everi hiv relat mortal worldwid studi aim determin surviv rate predictor mortal among tbhiv co infect patient institut base retrospect cohort studi undertaken adult tbhiv co infect individu st februari th januari mettu karl referr hospit cox regress model use identifi predictor surviv time death among tbhiv co infect patient studi compris tb hiv co infect adult patient among die censor studi subject follow person month overal median surviv time month overal incid rate per person month ci result multivari cox regress analysi show older age urban resid clinic stage ii iv cd count cellsmm bedridden function status use inh use cpt associ surviv time tb hiv co infect patient signific level alpha retrospect studi found high mortal tbhiv co infect patient occur earlier month treatment initi close monitor patient low cd util cpt advanc stage poor function level help improv health live longer
|
D060085;D015658;D014376
|
T047
|
36,319,733
|
quantifi impact land cover chang gross primari product global histor human clear mani forest agricultur substanti reduc ecosystem carbon storag impact land cover chang terrestri gross primari product gpp adequ resolv yet combin high resolut dataset satellit deriv gpp environment predictor variabl estim potenti gpp forest grassland cropland around globe mean gpp kg c yr forest repres product land cover two third total area suitabl land cover type grassland cropland averag reach kg c yr respect combin potenti gpp map histor land use reconstruct indic reduct global gpp agricultur expans land use induc gpp reduct amplifi futur scenario result ongo deforest eg larg scale bioenergi scenario ssp part revers scenario eg sustain scenario ssp due agricultur abandon compar result simul state art earth system model find investig model deviat substanti estim map could use benchmark reduc inconsist therebi improv project land base climat mitig potenti
|
D017753;D008962
|
T062;T070;T170;T082
|
36,319,732
|
attract healthi look male face show higher immunoreact previous research indic facial attract may provid cue function immun system mate individu effect immun system could lead higher reproduct success main aim test possibl associ immunoreact stimul vaccin perceiv facial attract healthi experiment activ immun system healthi men use vaccin hepat ab meningococcus measur level specif antibodi marker immun system reactiv day vaccin day vaccin collect facial photograph judg femal attract healthi facial skin patch healthi view propos connect function immun system also measur skin colour facial photograph vivo use spectrophotomet assess role attract healthi judgement moreov measur level steroid hormon testosteron cortisol percentag adipos tissu known immunomodulatori properti relat perceiv facial attract healthi found signific associ antibodi level induc vaccin perceiv facial attract facial healthi skin healthi also found signific connect steroid hormon level amount adipos tissu rate characterist antibodi level except small negat effect cortisol level perceiv facial healthi higher forehead red perceiv less attract less healthi higher cheek patch red perceiv less healthi signific associ found antibodi level facial colour overal result suggest perceiv facial attract healthi skin patch healthi provid limit cue immunoreact perceiv characterist seem relat cortisol level facial colour
|
D001504;D006854
|
T125;T121;T109;T080
|
36,319,731
|
associ waist circumfer chang incid chronic obstruct pulmonari diseas among chines adult year cohort studi aim studi investig waist circumfer wc chang risk incid chronic obstruct pulmonari diseas copd among chines adult total particip age year attend health examin repeat measur wc lung function forc vital capac fvc forc expiratori volum fev recruit wc chang categor accord sex modifi poisson regress model use assess associ wc gain risk copd year follow total copd case identifi baselin follow mean fev decreas l among male particip l among femal particip compar particip abdomin obes either baselin follow particip abdomin obes sex follow associ greater risk copd regardless abdomin obes baselin risk incid copd increas among male particip rr ci among femal particip rr ci wc gain increas year follow copd risk decreas among male particip wc chang rr ci risk incid copd posit associ increas wc among chines adult sex
|
D056128;D029424
|
T033;T184;T047
|
36,319,730
|
blockad blt ltb axi affect mast cell migrat toward advanc atherosclerot lesion ldlr mice mast cell associ progress destabil advanc atherosclerot plaqu reduc intraplaqu mast cell accumul upon atherosclerosi progress could potent therapeut strategi limit plaqu destabil leukotrien b ltb report induc mast cell chemotaxi vitro examin whether antagon ltb receptor blt could inhibit mast cell accumul advanc atherosclerosi express gene involv ltb biosynthesi determin singl cell rna sequenc human atherosclerot plaqu subsequ western type diet fed ldlr mice pre exist atherosclerosi treat blt antagonist cp vehicl control three time per week oral gavag spleen signific reduct cdb myeloid cell observ includ lyc lo lyc hi monocyt well dendrit cell howev atherosclerot plaqu size collagen macrophag content aortic root remain unalt upon treatment final blt antagon affect mast cell number aortic root show human intraplaqu leukocyt may sourc local produc ltb howev blt antagon atherosclerosi progress affect either local mast cell accumul plaqu size suggest mechan particip mast cell accumul atherosclerosi progress
|
D058226;D050197
|
T047;T046;T020;T031
|
36,319,729
|
silico vitro vivo character host associ latilactobacillus curvatus strain potenti probiot applic farm atlant salmon salmo salar salmon aquacultur fastest grow anim protein product system world howev intens farm lead poor weight gain stress diseas outbreak probiot offer potenti enhanc growth perform feed effici atlant salmon well immunostimul fish common pathogen benefit farmer consum effici product isol identifi nativ microbi isol includ lactobacilli farm salmon intestin base whole genom sequenc phylogenet analysi lactobacillus candid belong latilactobacillus curvatus l curvatus speci form two distinct phylogenet group use bioinformat vitro analys select two candid l curvatus atcc pta l curvatus atcc pta show desir safeti probiot properti two l curvatus candid evalu safeti efficaci higher final weight atlant salmon alongsid spore form bacilli isol salmon poultri swine test candid safe salmon advers effect see efficaci bacillus supplement group compar untreat group group administ two l curvatus strain consortium feed seven week freshwat show indic improv final bodi weight similar two l curvatus candid also evalu safeti efficaci atlant salmon saltwat group administ two l curvatus strain consortium feed week show indic improv final bodi weight comprehens metabolom analys presenc differ prebiot andor addit identifi galactooligosaccharid potenti prebiot enhanc efficaci two l curvatus candid togeth data provid comprehens genom phenotyp metabolom evid safeti desir probiot properti well indic vivo efficaci two novel endogen l curvatus candid potenti probiot applic atlant salmon vivo find need confirm larger perform studi includ field trial
|
D020317;D019936
|
T007;T013
|
36,319,728
|
associ metabol syndrom uric acid systemat review meta analysi systemat review meta analysi aim provid best evid associ metabol syndrom met uric acid ua determin size effect biomark met review protocol regist prospero crd search cover pubm scopus databas methodolog qualiti assess strobe tool overal risk bias revman cochran collabor qualiti evid grade pro initi articl identifi exclud duplic review titl abstract articl exclud appli elig criteria includ paper group compar ua concentr subject met control subject met higher mean ua mgdl ci p given heterogen includ studi research decid perform subgroup analysi men met higher ua concentr mgdl ci p women met ci p compar subject without met assess ua concentr could provid new avenu earli diagnosi met new biomark possibl new therapeut target
|
D014527;D024821
|
T123;T047;T114;T109
|
36,319,727
|
util synovi calprotectin later flow test exclud chronic prosthet joint infect periprosthet fractur prospect cohort studi diagnosi periprosthet joint infect pji requir combin various clinic laboratori microbiolog histopatholog paramet concomit periprosthet fractur ppf complic diagnosi caus confound local inflammatori respons synovi calprotectin demonstr promis biomark pji purpos present studi evalu reliabl synovi calprotectin pre intraop diagnosi pji pff patient ppf implant loosen includ prospect studi synovi fluid white blood cell percentag polymorphonuclear neutrophil serum c reactiv protein synovi calprotectin use later flow assay test ebji definit adjust threshold account local inflamm patient postop classifi confirm infect ten total hip arthroplasti fourtot knee arthroplasti calprotectin assay yield sensit specif posit predict valu negat predict valu calprotectin promis diagnost paramet detect pji ppf later flow assay offer prompt result may assist surgeon addit alreadi exist paramet pji diagnost diagnos concomit pji ppf surgeri
|
D057068;D016459;D001170;D019644
|
T061;T047;T046;T037
|
36,319,725
|
il gene ct exon rs nos exon polymorph associ earli asept loosen arthroplasti asept prosthet loosen apl prosthet joint infect pji frequent complic hip knee implant polymorph cytokin nitric oxid key inflammatori molecul apl pji pathogenesi could explain individu suscept complic three cytokin il il tnf two nitric oxid synthas nos nos gene polymorph genotyp apl pji patient control asept hip knee implant implant year plasma cytokin nitrat nitrit nox level also measur tt genotyp allel ct exon rs il polymorph frequent apl patient compar control p p respect genotyp associ pji patient observ plasma il tnf nox signific differ apl control p plasma il il signific higher apl allel carrier vs non carrier p knee implant hr ci p male gender hr ci p carriag tt genotyp ct il polymorph hr ci p aa genotyp exon nos polymorph hr ci p independ associ shorter implant surviv cox regress genotyp associ pji patient observ genotyp il ct exon rs nos exon polymorph could use predictor earli hip knee apl
|
D015850;D014409
|
T129;T116
|
36,319,724
|
gap fill ocean color tropic indian ocean use mont carlo method continu remot sens daili field ocean color span two decad howev still remain challeng examin ocean ecosystem process eg phenolog tempor frequenc less month due presenc signific larg gap satellit data caus cloud sun glint hardwar failur thus make gap fill prerequisit common use techniqu gap fill limit singl valu imput thus ignor error estim though conveni dataset fewer miss pixel techniqu introduc potenti bias dataset higher percentag gap tropic indian ocean summer monsoon satellit coverag reduc due season vari cloud cover studi fill miss valu tropic indian ocean set plausibl valu use classic mont carlo method prepar gap fill dataset ocean color use mont carlo method gap fill provid advantag estim phenolog indic uncertainti rang indic likelihood estim quantif uncertainti aris due miss valu critic address import under dataset henc motiv futur observ
|
D017753
|
T070;T082
|
36,319,723
|
electrocardiographi score predict heart failur hospit death beyond cardiovascular magnet reson imag electrocardiogram ecg cardiovascular magnet reson imag cmr provid power prognost inform aim determin relat prognost valu patient n undergo cmr lead ecg qrs durat ms includ prognosi score one year event free surviv hospit heart failur death deriv use continu ecg cmr measur multivari logist regress compar patient median interquartil rang age year femal event year ecg prognosi score includ frontal plane qrs angl heart rate correct qt durat qtc log rank cmr prognosi score includ global longitudin strain extracellular volum fraction log rank combin posit score ecg cmr yield highest prognost valu log rank multivari analysi show associ outcom ecg prognosi score log rank hazard ratio confid interv cmr prognosi score log rank hazard ratio ecg prognosi score predict outcom independ cmr combin result ecg cmr use prognosi score improv overal prognost perform
|
D004562;D006333
|
T060;T047;T074;T046
|
36,319,720
|
reveal low temperatur plasma efficaci dose rate assess dna damag detect combin machin learn model low temperatur plasma quick emerg altern unconvent type radiat offer great promis various clinic modal type radiat therapeut efficaci safeti low temperatur plasma ubiquit concern assess dose rate crucial clinic set unfortun assess dose rate standard dosimetr techniqu challeng overcom difficulti propos dose rate assess framework combin predict model plasma induc damag dna machin learn exist radiat dose dna damag correl result indic low temperatur plasma remark high dose rate tune various process paramet attribut benefici induc radiobiolog effect control manner
|
D000069550;D011853
|
T091;T066
|
36,319,719
|
testi express gene inhibit cisplatin induc dna damag contribut chemoresist testicular germ cell tumor testicular germ cell tumor tgct rare cancer common tumor among adolesc young adult male patient advanc tgct often exhibit wors prognosi due acquisit therapeut resist cisplatin base chemotherapi standard treatment advanc tgcts initi sensit cisplatin exemplifi embryon carcinoma acquisit cisplatin resist howev could fatal obstacl tgct manag identifi cisplatin resist relat gene perform transcriptom analysi cisplatin resist tgct cell compar parent cell two type cisplatin resist tgct cell model establish patient deriv tgct cell nec cell line found mrna level high mobil group nucleosom bind gene hmgn meiosi relat gene tex remark upregul compar correspond parent cell show either hmgn tex knockdown substanti reduc viabil cisplatin resist tgct cell presenc cisplatin notabl tex silenc cisplatin resist tgct cell increas level cleav parp protein percentag doubl strand break marker hax posit cell demonstr therapeut effici tex specif sirna vivo xenograft model deriv cisplatin resist patient deriv tgct cell taken togeth present studi provid potenti insight mechan cisplatin resist via tex depend pathway inhibit apoptosi dna damag expect find appli improv cisplatin base chemotherapi tgct particular tex overexpress tumor
|
D009373;D013736
|
T191
|
36,319,718
|
lumbar punctur safeti toler premanifest manifest huntington diseas multi analysi cross section studi lumbar punctur lp becom increas common peopl huntington diseas hd administ intrathec investig medicin product collect cerebrospin fluid develop biolog marker track diseas stage progress aim investig safeti profil lp peopl hd build recent publish work increas sampl size specif increas represent premanifest popul healthi control conduct multi studi cross section analysi includ elig particip hdclariti huntington diseas gene expans carrier control hd yas studi premanifest control enrol februari septemb investig odd advers event headach back pain independ intergroup comparison adjust event odd deriv use hierarch logist regress total lp procedur involv particip includ analysi lp procedur associ one advers event two common advers event post lp headach back pain younger age femal gender found associ higher risk develop advers event differ rate advers event diseas subgroup adjust covari age gender result suggest lp safe toler premanifest manifest hd subject provid use reassur procedur hd communiti
|
D006816
|
T047
|
36,319,715
|
technic sign anthropogenesi vygotski leroi gourhan stiegler paper reconstruct ls vygotski account anthropogenesi respect work anthropologist andr leroi gourhan late philosoph bernard stiegler situat vygotski forerunn recent theori posit cultur scaffold nich construct main driver human cognit evolut one might think immedi affin vygotski techno centric account leroi gourhan stiegler follow leroi gourhan stiegler argu technic main driver anthropogen develop reflect conscious vygotski likewis claim psycholog tool respons develop uniqu human form conscious howev closer inspect reveal deep dispar vygotski french thinker stiegler philosoph redeploy leroi gourhan anthropolog reflect cognit product prehistor ruptur threshold technic cortic complexif breach vygotski hand invers scenario obtain technic develop initi proceed tandem complexif biolog base signal behavior introduct sign radic restructur cognit apparatus due inconsist regard equival technic semiot stiegler leroi gourhan advanc vygotskian account anthropogenesi result semiot rather technic intervent aim establish vygotski cultur histor approach marxian dialect tradit draw presag recent naturalist account develop offer relev theoret program may continu inspir contemporari encultur account anthropogenesi
|
D000883;D007802
|
T090;T171
|
36,319,710
|
antimicrobi prebiot activ mannoprotein isol convent nonconvent yeast speci studi select microorgan yeast mannoprotein propos paraprobiot antimicrobi prebiot properti use biopreserv food diseas therapi knowledg specif andor capabl influenc growth differ microorgan limit studi determin effect mannoprotein prepar saccharomyc cerevisia cerevisia atcc nonconvent yeast origin metschnikowia reukaufii reukaufii wlp wickerhamomyc anomalus w anomalus cci growth select bacteria genera lactobacilllus limosilatobacillus limosilatobacillus bifidobacterium staphylococcus enterococcus pseudomona escherichia proteus salmonella degre stimul growth inhibit test bacteria depend type dose mannoprotein bacteri strain addit test prepar entir rang appli concentr posit effect especi growth lactobacillus arabinosus atcc bifidobacterium animali subsp lacti b mannoprotein isol cerevisia limit growth escherichia coli e coli atcc pseudomona aureoginosa p aureoginosa atcc proteus mirabili atcc salmonella enteritidi atcc greatest extent prepar reukaufii w anomalus origin effect limit growth staphylococcus aureus strain e coli p aureoginosa growth enterococcus faecali stimul presenc studi prepar concentr use research determin purif process studi mannoprotein oligosaccharid fraction structur composit influenc growth select bacteria mechan activ
|
D012441;D000890
|
T121;T004
|
36,319,709
|
polymorph phylogenet analysi fecb fecg gene nativ sheep meghalaya india present studi conduct identifi polymorph two major fecund gene viz fecb fecg indigen sheep meghalaya assess phylogenet relationship breed sheep estim sequenc distanc blood sampl collect adult ewe pcr rflp perform detect polymorph gene digest fecb fecg done restrict enzym avaii ddei respect case fecb gene two genotyp viz aa ab identifi aa genotyp yield one fragment bp ab genotyp yield two fragment bp frequenc b allel calcul aa ab genotyp respect wherea fecg gene found monomorph singl genotyp design ab genotyp measur related among indian exot sheep term fecund gene threw light evolutionari origin differ sheep breed
|
D011110;D005298
|
T071;T032;T055;T040;T062;T045
|
36,319,708
|
longitudin metabolom profil reveal sex specif adjust long durat spaceflight return earth spaceflight entail varieti environment psycholog stressor may long term physiolog genom consequ metabolom approach investig termin metabol output complex physiolog alter consid dynam state human bodi allow identif quantif stream metabolit link stream physiolog genom regul stress employ metabolom base approach studi investig longitudin metabol perturb male n femal n astronaut month mission intern space station iss proton nuclear magnet reson h nmr spectroscopi follow univari multivari machin learn analys use blood serum examin sex specif metabol chang various time point throughout astronaut mission metabol effect long durat space travel space travel result sex specif chang energi metabol bone miner muscl regul immun well macromolecul mainten synthesi addit metabol signatur suggest differenti metabol respons especi recoveri period femal requir time adjust return earth find provid insight perturb glucos amino acid metabol macromolecul biosynthesi result stressor long durat spaceflight metabolom biomark may provid viabl approach predict diagnos health risk associ prolong space travel physiolog challeng earth
|
D013026
|
T057
|
36,319,705
|
metabol adapt atp homeostasi pseudomona fluorescen expos phosphat stress phosphat pi essenti life integr part univers chemic energi adenosin triphosph atp macromolecul dna rna protein lipid despit core role need nutrient live cell bacteria grow environ poor pi metabol mechan enabl bacteria prolifer low phosphat environ fulli understood studi soil microb pseudomona p fluorescen cultur control low pi stress medium order delin energi homeostasi maintain although signific variat biomass yield cultur metabolit like isocitr oxaloacet pyruv phosphoenolpyruv pep mark increas phosphat starv condit compon glycolyt glyoxyl tricarboxyl acid cycl oper tandem generat atp substrat level phosphoryl slp nadh produc enzym imped ketoglutar kg produc glutamin sole carbon nutrient transform phosphoenol pyruv pep succinyl coa sc two high energi moieti metabol reprogram orchestr isocitr lyas icl phosphoenolpyruv synthas pep pyruv phosphat dikinas ppdk succinyl coa synthetas fulfil atp budget cell free extract experi confirm atp synthesi presenc substrat pep oxaloacet isocitr respect gene express profil reveal elev transcript associ numer enzym includ icl pep succinyl coa synthetas scs microbi adapt critic promot biolog activ pi poor ecosystem
|
D011551
|
T007
|
36,319,704
|
therapeut plasma exchang multipl sclerosi patient aggress relaps observ analysi high volum center evid base treatment multipl sclerosi ms relaps intraven administr g methylprednisolon case insuffici effect corticosteroid intoler therapeut plasma exchang tpe indic assess clinic effect tpe treatment relaps patient relaps remit ms rrms enrol patient meet follow criteria studi period januari februari age rrms accord mcdonald criteria ms relaps insuffici effect corticosteroidscorticosteroid intoler baselin edss exclus criteria progress form diseas histori previous tpe follow paramet monitor edss chang corticosteroid treatment tpe edss tpe assess next clinic follow ms center improv edss accord number procedur baselin sever relaps femal male includ median age year iqr patient underw puls corticosteroid treatment tpe patient underw tpe without previous corticosteroid treatment median baselin edss iqr median edss finish steroid iqr edss prior tpe iqr edss tpe iqr observ signific improv edss tpe p p total tpe count p retrospect studi patient aggress relaps insuffici effect intraven corticosteroid treatment signific effect tpe edss improv observ signific differ tpe effect accord number procedur age sever relaps cohort tpe effect femal
|
D009103;D020529
|
T047
|
36,319,701
|
amplitud synchron spontan activ medial later tempor gyri reveal alter thalam connect patient tempor lobe epilepsi studi examin whether amplitud synchron medial mtl later ltl tempor lobe detect uniqu alter patient mtl epilepsi mtle mesial tempor sclerosi mts retrospect studi preoper rest state fmri rsfmri data patient mtle mts age control age fmri data preprocess base multistep preprocess pipelin regist standard space use subject weight scan mtl ltl automat segment manual revis fit standard space use symmetr normal registr algorithm dual regress analysi appli preprocess rsfmri data detect amplitud synchron medial later tempor segment rest brain calcul overlap volum ratio synchron voxel within specif target region includ thalamus total bilater general linear model use bonferroni correct covari epilepsi durat age patient scan statist compar synchron patient mtle mts control well respect whether patient remain seizur free sf nsf receiv epilepsi surgeri found increas ipsilater posit connect ltls thalamus contralater negat connect mtls thalamus patient mtle mts compar control also found increas asymmetri function connect tempor lobe subregion thalamus patient mtle mts increas posit connect ltl lesion side thalamus well increas negat connect mtl nonlesion side thalamus asymmetri also seen nsf patient seen sf patient control amplitud synchron effect method detect function connect alter patient mtle mts patient mtle mts overal show increas tempor thalam connect increas function involv thalamus mts underscor role seizur spread increas function thalam asymmetri pattern nsf patient may potenti role prognost patient respons surgeri elucid region alter function connect tempor region improv understand involv differ region diseas potenti target intervent use prognosi surgeri futur studi need examin effect use patient specif abnorm pattern predict surgic outcom
|
D004833
|
T047
|
36,319,699
|
evid air pollut relat ocular sign alter inflammatori cytokin profil ocular surfac beij evalu differ degre air pollut affect ocular surfac cohort human subject beij correl patient test outcom tear cytokin cross section studi involv volunt carri differ district beij air pollut indic record includ visit day indic record air qualiti index aqi dimensionless measur quantit describ state air qualiti concentr particul matter smaller pm pm sulfur dioxid ozon nitrogen dioxid ocular symptom diseas index osdi questionnair provid subsequ subject underw slit lamp examin includ meibomian gland examin conjunctiv congest score conjunctivochalasi grade tear meniscus height tmh tear breakup time tbut corneal fluorescein stain cfs schirmer test conjunctiv impress cytolog concentr vascular endotheli growth factor vegf interleukin il il il tear measur microspher base immunoassay analysi accord valu aqi particip divid slight pollut sp group n aqi valu less equal heavili pollut hp group n whose aqi valu air pollut relat ocular discomfort base tear cytokin concentr pm pm posit correl osdi mg express meibum score meiboscor conjunctiv congest score schirmer test valu tmh goblet cell densiti concentr il vegf negat correl tbut pm pm appear major risk factor ocular surfac anoth import risk factor base studi symptom sign eye discomfort sp group signific less sever hp group tear cytokin concentr il vegf lower air pollut degre signific correl tear cytokin concentr indic alter cytokin balanc ocular surfac differ degre air pollut
|
D000397;D015352
|
T184;T047;T069;T080
|
36,319,691
|
characterist intermedi age relat macular degener hyperreflect foci hyperreflect foci hrf find observ optic coher tomographi oct sever retin diseas believ associ increas risk atrophi eye age relat macular degener amd studi investig clinic genet characterist intermedi amd hrf review medic chart patient intermedi amd macular neovascular mnv observ contralater eye presenc absenc hrf evalu use spectral domain oct volum scan span macular region patient follow longitudin least month maximum follow period month genotyp arm cfh iv perform particip patient mean age year malefemal hrf observ eye signific associ type mnv p contralater eye pseudodrusen p thinner subfov choroid thick p risk arm p follow eye develop advanc amd mean time onset advanc amd month eye intermedi amd hrf associ mnv p atrophi
|
D015593;D008268
|
T047
|
36,319,690
|
x ray crystalograph data absolut configur anticholinesteras effect dihydromyricitrin rhamnosid base continu effort investig chemistri biolog plant secondari metabolit abl isol glycosid flavonoid wild egyptian artichok activ dihydromyricetin rhamnosid sin dihydromyricitrin ampelopsin rhamnosid acetylcholinesteras ach butyrylcholinesteras bche absolut configur use x ray crystallographi determin first time inhibitori activ ach bche enzym determin use slight modifi version ellman method compound reveal potent inhibit acetylcholinesteras ach butyrylcholinesteras bche ic valu mm respect ic valu refer drug galanthamin mm compound could promis molecul alzheim diseas
|
D002800;D002091
|
T121;T126;T116;T109
|
36,319,689
|
quantit analysi choroid vasculatur central serous chorioretinopathi use ultra widefield swept sourc optic coher tomographi angiographi aim quantit compar choroid blood flow choroid thick peripheri among eye central serous chorioretinopathi csc fellow eye healthi eye use ultra widefield swept sourc optic coher tomographi angiographi uwf ss octa retrospect analysi patient csc eye includ unaffect fellow eye age sex match control includ obtain dimension data vertic mm horizont mm scan depth mm compris subfield superotempor upper superonas tempor central nasal inferotempor lower inferonas region csc eye present greater densiti larg vessel choroid layer subfield compar control compar normal eye csc eye greater choroid thick superotempor upper superonas tempor central nasal inferotempor inferonas subfield choroid volum superotempor upper superonas tempor central nasal subfield compar control eye choriocapillari densiti superotempor inferotempor inferonas subfield greater patient csc studi may provid evid congest vortex vein pathogenesi csc uwf ss octa use evalu abnorm choroid structur even peripheri eye csc
|
D056833
|
T047
|
36,319,688
|
influenc chines scholar global research rise china scientif research superpow frequent discuss media literatur howev past analys usual base geograph databas ignor million emigr chines student consid major research workforc mani countri affect academ output quantit analyz contribut chines scholar physic scienc around globe public countri paper well citat contrari common percept find increas number chines scholar correl net public growth declin host countri chines popul exceed critic valu hand increas chines author paper improv citat phenomena though anomal observ mani subfield physic across globe analysi suggest although chines scholar chang perceiv public capabl mani countri may reshap research cultur well workforc distribut result would valuabl r higher educ immigr policymak
|
D034941
|
T023
|
36,319,687
|
analysi deviat classic formula see text law biochar convers oxygen enrich temperatur control environ combust char convent report diffus control analyt process report follow second order initi diametr formula see text depend formula see text singl film co combust two film model co burn concentr sphere particl howev experiment investig indic deviat classic diffus limit formula see text exceed go high videographi investig depict lumin film engulf particl certain temperatur oxygen concentr particl diamet combin formula see text observ deviat hypothes convect resist offer co generat surfac motion formula see text toward surfac result reduc formula see text concentr surfac enhanc convers time implic henc formula see text convect resist remain unaccount prevail analyt model co domin film thick enhanc temperatur reactant concentr increas convect resist deviat formula see text behaviour analyt solut show presenc convect expand co film total convers time function film diamet also depend formula see text hypothesi valid compar analyt estim experiment observ film diamet convers time
|
D010100;D002606
|
T123;T196;T121;T109
|
36,319,683
|
excess suicid attribut covid pandem social dispar south korea impact covid pandem suicid remain unclear might differ accord individu socioeconom characterist aim investig excess suicid attribut covid south korea stratifi outbreak period individu characterist obtain daili time seri suicid mortal data januari decemb korea nation statist offic perform two stage interrupt time seri analysi estim excess suicid region korea use quasi poisson time seri regress model pool region specif estim use mix effect multivari meta analysi model first second stage respect februari decemb suicid decreas empir confid interv eci compar number expect pre pandem period decreas excess suicid risk initi pandem pronounc pandem first third wave found decreas suicid evid individu male eci middl age eci high educ eci marri eci general popul base point estim result provid time evid establish public health polici suicid prevent suggest priorit resourc alloc mental health individu base individu characterist
|
D000086382;D013405
|
T033;T047;T067
|
36,319,682
|
experiment studi microstructur characterist satur remold cohes soil consolid paper drain consolid test satur remold cohes soil carri differ load rate sampl differ load stage measur nuclear magnet reson nmr test qualit analysi relationship transvers relax time peak area poros deform micro respons satur remold cohes soil studi result show transvers relax time satur remold cohes soil sampl initi stage consist two spectral peak repres pore larg small pore diamet respect load progress pore diamet sampl group gradual shift smaller size final form spectrum unimod pore becam denser uniform initi stage load spectrum soil sampl faster load show obvious chang trend due influenc drainag lag suffici long dead load time final shape spectrum similar regardless load rate indic load rate affect intermedi state soil sampl final state determin initi state sampl time certain dead load time chang pore diamet longer obvious indic flow fluid pore drain drainag consolid complet accord posit correl load rate maximum pore pressur boundari rate obtain could reason infer control load rate less valu drainag consolid complet main consolid stage
|
D012987
|
T167
|
36,319,681
|
extrem obes strong predictor hospit mortal preval long covid sever covid patient acut respiratori distress syndrom acut respiratori distress syndrom ard common covid patient associ high mortal aim observ studi describ patient characterist outcom identifi potenti risk factor hospit mortal develop long covid symptom retrospect studi includ patient covid associ ard card period march march invas ventil intens care unit icu univers hospit dresden germani octob decemb patient discharg aliv minimum month hospit discharg midterm surviv contact interview persist symptom possibl associ covid well qualiti live use eq l questionnair long covid defin occurr one symptom least month discharg risk factor mortal assess cox regress model risk factor develop long covid symptom use relat risk rr regress patient includ studi male n median age rang patient diagnos ard accord berlin definit patient n sever ard horovitz index kgm identifi independ risk factor hospit mortal develop long covid symptomstri registr drks id drks
|
D000086382;D012128
|
T047;T067
|
36,319,680
|
physiolog status anatom sever factor associ child versus adult bicyclist fatal base nation trauma dataset bicyclist still account major child death traffic accid despit gradual decreas incid therefor investig factor associ child adult bicyclist fatal retrospect studi use data nation hospit base databas japan trauma data bank data obtain child cyclist year n adult cyclist year n age group physiolog variabl outcom injuri sever compar fatal non fatal case multivari logist regress perform determin factor associ fatal adult fatal associ lower valu bodi temperatur glasgow coma scale score abbrevi injuri scale ai score neck upper extrem higher valu respiratori rate heart rate focus assess sonographi trauma posit rate ai score head chest abdomen children fatal associ lower valu bodi temperatur glasgow coma scale score higher valu ai chest score find point factor associ bicyclist fatal may help develop effect strategi reduc fatal
|
D001642;D000063
|
T056;T037;T067
|
36,319,679
|
citrat effect swell behaviour stabil casein microparticl casein microparticl obtain casein micell volum exclus ad pectin subsequ film dri remain stabl acid neutral ph rang swell strong basic rang calcium signific impact stabil water bind behavior phosphoryl casein aggreg gel form futur effect control use carrier bioactiv substanc eg via gastrointestin tract therefor investig addit calcium chelat agent citrat affect swell stabil microparticl citrat concentr mm caus stronger swell microparticl ph mm second characterist swell step start earlier thus also investig within observ time min swell kinet simul use seven paramet dynam model reproduc individu swell step via volum inflow outflow reservoir rate coeffici swell step increas linear citrat concentr depend could found swell step citrat use faster microparticl decompos turbid experi addit sodium dodecyl sulfat relat weaken hydrophob interact
|
D002364;D019343
|
T123;T121;T116;T109
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.